Pharmaceutical firm G1 Therapeutics scored USD 12.5 million from MedImmune Ventures and other investors in its Series A funding round.
Series A
Secure messaging app Cureatr nabs USD5.7 million in Series A funding round
Cureatr's primary product, a secure messaging app for doctors, received significant backing from investors including Milestone Venture Partners and Cardinal Partners.
Teads gets USD 5.2 million in Series A funding round
Teads closed its Series A investment round with USD 5.2 million from Partech Venture and Elaia Partners.
Sideris Pharmaceuticals receives USD 32 million in Series A funding round, strikes deal with Novartis
Sideris Pharmaceuticals Inc received USD 32 million in capital commitments in its Series A funding round.
Applift receives investment funds from Prime Ventures
Prime Ventures invests in mobile games platform AppLift. An additional investment of USD7 million from Prime Ventures was received by mobile games marketing platform AppLift.
Latest News
Mobile financial solutions provider Level initially closed its Series A funding round with USD 5 million.
In its latest Series A funding round, TempoDB would be expanding and developing its sensor and measurement data storage systems.
Venture funding amounting to USD1.5 million in venture funding was received by elevate DIGITAL for its expansion and development purposes.
Pharmakea Therapeutics receive funding through Series A round from Bay City Capital and Celgene Corporation.
